The Economics of New Product Launches and Access to Pharmaceutical Products in the EU
The authors provide an economic perspective on the European Commission’s proposed reform of the EU’s pharmaceutical legislation.
In re HIV Antitrust Litigation
The jury found in favor of the defense concluding, consistent with Dr. Saravia’s testimony, that the settlement contained no payment for delay.
The Inflation Reduction Act Could Have Unintended Consequences
This article analyzes the potential unintended economic impacts of the Inflation Reduction Act on the pharmaceutical industry.
American Conference Institute: 14th Summit on Biosimilars & Innovator Biologics
Alice Chen of the USC Sol Price School of Public Policy will discuss the impact of the Inflation Reduction Act (IRA) at this annual event.
Expert Network for Women in Healthcare and Life Sciences
This network connects women economists and academics working on healthcare and life sciences topics and offers an opportunity to learn about expert witness work.
Bringing New Science to Market
Sean Nicholson of Cornell University will speak at this event about innovation, adoption, and policy challenges in the healthcare industry.
ASHEcon 2023: The Annual Conference of the American Society of Health Economists
Caitlyn Fleming will speak at this annual event about the varied settings in which health economists contribute expertise.
21st Annual International Industrial Organization Conference (IIOC)
Cornerstone Research affiliated experts will be honored and present at this annual conference in Washington, DC.
Life Sciences Capabilities
From initial strategy through deposition and trial, clients have used our findings in hundreds of matters involving the life sciences industry.
Intersection of Intellectual Property and Competition Policy in Recent Cases
The authors discuss high-profile cases in the EU and US that concern IP rights and competition policy.
Why Curve-Fitting Cannot Be Used to Show Causation or Estimate Impact
Iain Cockburn discusses the problems with curve-fitting methodology in economic analysis in this Westlaw article.
Evaluating Innovation Theories of Harm in Merger Review: Economic Frameworks and Difficulties
The authors discuss recent life science cases that deal with innovation theories of harm, and what economic models can be useful in reviewing proposed mergers in this space.
How can we help you?
If you are looking for a publication not on our website, contact us.